Good afternoon, readers.

Say you stroll right into a hospital or different COVID vaccine distribution website. You qualify to get one since you’re a precedence group beneath native laws, and there are sufficient out there doses round so that you can get one. Which one would you really obtain?

The Meals and Drug Administration (FDA) has already granted emergency authorization to 2 of them, one from Pfizer and its German companion BioNTech and the opposite from Moderna. However you’re unlikely to know which one of those you’ll be getting.

This pandemic has had a unifying theme: Triage. You get the assets to who wants them most. You allocate such assets accordingly. That was the case with coronavirus testing at the start of the outbreak. Now it’s the case for one of the crucial complicated immunization campaigns in historical past.

Whereas the Pfizer and Moderna vaccines share scientific roots, they’re nonetheless very totally different merchandise with totally different logistical necessities akin to storage and dosing (although they’ve been proven to be equally efficient in scientific trials). However location will almost certainly dictate precisely which shot you obtain.

Dwell close to a serious, sprawling, subtle well being system? You would possibly get Pfizer’s vaccine, which has ultra-cold storage necessities {that a} smaller hospital might not have the instruments to handle. Dwell in a rural space? Maybe Moderna’s vaccine, which doesn’t require these extra specialised capabilities.

Maintaining monitor of all that is key since mixing up two totally different vaccines could possibly be harmful (a reality which has pressured well being techniques to work with digital well being report distributors to control who’s getting what).

All of it boils all the way down to flexibility, and extra vaccines will ultimately arrive to the market. However the disparate methods for COVID vaccine deployment might additionally breed some confusion.

On a associated observe, the worldwide pandemic has uncovered deficiencies in well being techniques all over the place and has highlighted the significance of advancing with extra patient-centric options.

What’s extra, the transformative spirit and pace of change—from therapeutics to the current vaccine growth and deployment—have demonstrated that well being techniques will be extra environment friendly in assembly calls for at the moment and tomorrow. You can join Fortune for a special conversation on these topics and more, presented in partnership with Roche, on January 21 at 11 a.m. to 12 p.m. ET.

Learn on for the day’s information, and see you subsequent week.

Sy Mukherjee